JUN-Mediated downregulation of EGFR signaling is associated with resistance to gefitinib in EGFR-mutant NSCLC cell lines

Mutations or deletions in exons 18–21 in the epidermal growth factor receptor (EGFR) are present in approximately 15% of tumors in patients with non-small cell lung cancer (NSCLC). They lead to activation of the EGFR kinase domain and sensitivity to molecularly targeted therapeutics aimed at this do...

全面介紹

Na minha lista:
書目詳細資料
發表在:Mol Cancer Ther
Main Authors: Kani, Kian, Garri, Carolina, Tiemann, Katrin, Malihi, Paymaneh D., Punj, Vasu, Nguyen, Anthony L., Lee, Janet, Hughes, Lindsey D., Alvarez, Ruth M., Wood, Damien M., Joo, Ah Young, Katz, Jonathan E., Agus, David B., Mallick, Parag
格式: Artigo
語言:Inglês
出版: 2017
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5558834/
https://ncbi.nlm.nih.gov/pubmed/28566434
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-16-0564
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍